Abstract
Amelogenesis imperfecta (AI) is a genetically inherited disorder characterized by defective enamel formation, posing a significant challenge in esthetic treatment for clinicians. The choice of an appropriate treatment modality is largely dictated by the specific type of AI. This paper aims to elaborate on therapeutic options available for patients under 18 with amelogenesis imperfecta, emphasizing a multidisciplinary treatment approach.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call